Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susan Kalota
Observed names:
S Kalota,
S. Kalota,
SUSAN J. KALOTA,
Susan J. Kalota,
Susan Jones Kalota
Institutions:
Memorial Sloan Kettering Cancer Center,
Sidney Kimmel Center for Prostate and Urologic Cancers
Observed institutions:
Memorial Sloan Kettering Cancer Center,
University of California San Diego,
Rady Children's Hospital-San Diego,
Urology of Virginia,
University of California San Diego Medical Center,
Sidney Kimmel Center for Prostate and Urologic Cancers
show all 6
OpenAlex ID:
A5012058407
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
2021
·
Renato D. Lopes
, Celestia S. Higano
, et al.
·
Circulation
·
173
Infantile Hypertrophic Pyloric Stenosis and Hydronephrosis: Is there an Association?
1993
·
Mohamed Bidair
, Susan J. Kalota
, et al.
·
The Journal of Urology
·
19
Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement
2018
·
Neal Shore
, Ronald Tutrone
, et al.
·
World Journal of Urology
·
16
PDF
Clinical results of a phase 1 study of intravesical EG-70 in patients with BCG-unresponsive NMIBC.
2023
·
Gary D. Steinberg
, Susan J. Kalota
, et al.
·
Journal of Clinical Oncology
·
14
Prevention of Acrolein-Induced Bladder Injury by Pentosanpolysulfate
1992
·
Susan Jones Kalota
, Paul C. Stein
, et al.
·
The Journal of Urology
·
14
Small Intestinal Submucosa Tension-free Sling: Postoperative Inflammatory Reactions and Additional Data
2004
·
SUSAN J. KALOTA
·
The Journal of Urology
·
13
Twelve-Month Efficacy and Safety Data for the “Stress Incontinence Control, Efficacy and Safety Study”: A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon
2017
·
Harvey Winkler
, Karny Jacoby
, et al.
·
Urogynecology
·
7
P2-08 Legend: a Phase 1/2 Study of Eg-70 (detalimogene Voraplasmid), a Novel, Non-viral Intravesical Gene Therapy for Patients With Bcg-unresponsive Non-muscle Invasive Bladder Cancer With Carcinoma in Situ (cis)
2024
·
Susan Kalota
, Shreyas Joshi
, et al.
·
The Journal of Urology
·
6
PDF
Three‐month primary efficacy data for the SUCCESS Trial; a phase III, multi‐center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon
2017
·
Kurt McCammon
, Karny Jacoby
, et al.
·
Neurourology and Urodynamics
·
6
PDF
Gene Therapy With URO-902 (pVAX/ hSlo ) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial
2025
·
Ekene A. Enemchukwu
, Susan Kalota
, et al.
·
The Journal of Urology
·
5
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results
2020
·
Neal Shore
, Steven A. Kaplan
, et al.
·
World Journal of Urology
·
3
PDF
Ip54-20 Longitudinal Cystoscopic Evaluation of a Next Generation Prostatic Urethral Implant: Evaluation Over 12 Months
2026
·
Bilal Chughtai
, Deborah Jakubowicz
, et al.
·
The Journal of Urology
·
2
PDF
Three-month primary efficacy and six-month treatment arm results from the SUCCESS study of an intravesical balloon to treat female stress urinary incontinence (SUI)
2017
·
E. Rovner
, K. Jacoby
, et al.
·
European Urology Supplements
·
2
Efficacy and Safety of Zenflow Prostatic Spring for Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia; Results From a Pivotal Ide Clinical Trial
2026
·
Dean Elterman
, Susan Kalota
, et al.
·
The Journal of Urology
·
1
PDF
Abstract PR006: EG-70 (detalimogene voraplasmid), a novel, non-viral intravesical gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: Preclinical characterization and translation into the clinic
2024
·
Marie-Line Goulet
, Shauna M Dauphinee
, et al.
·
Clinical Cancer Research
·
1
Lba01-19 Long-term Efficacy and Safety of Uro-902 (pvax/ Hslo ) in Women With Overactive Bladder and Urge Urinary Incontinence: Final Results of a Phase 2a Trial
2023
·
Kenneth M. Peters
, Ekene A. Enemchukwu
, et al.
·
The Journal of Urology
·
1
PDF
6 Efficacy and Safety of a Novel Gene Therapy (uro-902; Pvax/hslo) in Female Patients With Overactive Bladder Syndrome and Urgency Urinary Incontinence: Results From a Phase 2a Trial
2022
·
K Peters
, E Enemchukwu
, et al.
·
Continence
·
1
PDF
Ip29-27 Patient Satisfaction After 12 Months Using the Zenflow Spring System for Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
2026
·
Brian Mazzarella
, Bilal Chughtai
, et al.
·
The Journal of Urology
PDF
Pllba-03 Efficacy and Safety of a Novel Gene Therapy (uro-902; Pvax/hslo) in Female Patients With Overactive Bladder and Urge Urinary Incontinence: Results From a Phase 2a Trial
2022
·
Kenneth Peters
, Ekene Enemchukwu
, et al.
·
The Journal of Urology
Mp67-10 Redirecting a Global Health Surgical Program to Remote Support During a Pandemic: the Ivu Virtual Visiting Professorship Program
2021
·
Sanjay Das
, Frank Burks
, et al.
·
The Journal of Urology
Mp65-09 Analysis of Uti Resolution and Sediment Formation on Intravesical Balloon for the Treatment of Sui From Two Multicenter Randomized Controlled Studies
2016
·
Karny Jacoby
, Stephan De Wachter
, et al.
·
The Journal of Urology
PDF
Analysis of Sediment Formation on Long Term Indwelling Free-floating Intravesical Balloons for the Treatment of Sui From Two Multicenter Randomized Controlled Clinical Studies.
2015
·
Stefan De Wachter
, Jean‐Jacques Wyndaele
, et al.
·
ics.org
Show more works
View as search
Works count:
22
Citation count:
284
H-index:
7
I10-index:
6
Year
Topic
Type